| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8272092 | Journal of Geriatric Oncology | 2018 | 8 Pages |
Abstract
Challenges were experienced in conducting the first prospective phase III study evaluating progression-free survival of older adults with advanced colorectal cancer receiving palliative chemotherapy with fluoropyrimidine/bevacizumab with or without oxaliplatin in the USA. Future efforts to evaluate treatment outcomes in the older adult population should reflect on lessons learned in this large national effort.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Nadine J. McCleary, Joleen Hubbard, Michelle R. Mahoney, Jeffrey A. Meyerhardt, Daniel Sargent, Alan Venook, Axel Grothey,